Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

HOPA 2018 | HOPA 2018/19: what’s next?

Susannah Koontz • 22 Mar 2018
HOPA 2018
General

What can be expected from the Hematology/Oncology Pharmacy Association (HOPA) in 2018/19? Here, Susannah Koontz Webb, PharmD, BCOP, FHOPA, 2017/18 President of HOPA, discusses exciting new developments that are expected to begin in the upcoming year for HOPA. From forming an oral oncolytic institute to talks on establishing HOPA’s very own journal, Dr Koontz Webb provides an exciting insight into the initiatives and tools being explored to improve care for cancer patients and support Hematology/Oncology Pharmacists. This interview was recorded at the 2018 HOPA Annual Conference, held in Denver, CO.

More from Susannah Koontz

3:43
HOPA: supporting oncology pharmacy education and professional development
Susannah Koontz • 22 Mar 2018
3:01
The 2018 HOPA conference: targeting the future of oncology pharmacy
Susannah Koontz • 22 Mar 2018
1:36
Thoughts on HOPA: the 2017/18 President’s perspective
Susannah Koontz • 22 Mar 2018
2:07
The importance of HOPA membership: being not only a member, but an asset
Susannah Koontz • 22 Mar 2018

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals